PFM HEALTH SCIENCES, LP Holdings

PFM HEALTH SCIENCES, LP is an investment fund managing more than 2.76B US dollars. The largest holdings include Cytokinetics, Incorporated, Eli Lilly and Company and BioMarin Pharmaceutical. In Q3 2022 the fund bought assets of total value of 394.23M US dollars and sold assets of total value of 402.51M US dollars.

$2.76B

portfolio value

-0.39%

quarter

-23.38%

1 year

+11.57%

3 years

+11.47%

5 years

PFM HEALTH SCIENCES, LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	983693000	1404760000
Q2 2016	1107018000	1354467000
Q3 2016	1530647000	926084000
Q4 2016	1170739000	1401892000
Q1 2017	1605959000	1061790000
Q2 2017	1391144000	1485335000
Q3 2017	1433188000	780335000
Q4 2017	1097682000	1162049000
Q1 2018	1458327000	842780000
Q2 2018	1454724000	828130000
Q3 2018	1226538000	1021761000
Q4 2018	683692000	2466665000
Q1 2019	1231424000	1131835000
Q2 2019	1244088000	964024000
Q3 2019	1252618000	1795981000
Q4 2019	587515000	2011396000
Q1 2020	406922000	763215000
Q2 2020	686611000	294587000
Q4 2020	908325000	335845000
Q1 2021	798750000	357052000
Q2 2021	406435000	206646000
Q3 2021	544657000	378535000
Q4 2021	369599000	550244000
Q1 2022	316618000	462496000
Q2 2022	477537000	434176000
Q3 2022	394231000	402506000

PFM HEALTH SCIENCES, LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Cytokinetics, Incorporated Portfolio share: 4.32% Portfolio value: 119.43M Avg. open price: $20.28 Current price: $38.12 P/L: +87.93% Sold -21.99% shares Q4 2021	share	4.32%	119.43M	$20.28	$38.12	+87.93%	Sold -21.99% shares Q4 2021
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 3.49% Portfolio value: 96.56M Avg. open price: $166.32 Current price: $369.29 P/L: +122.03% Sold -43.16% shares Q4 2021	share	3.49%	96.56M	$166.32	$369.29	+122.03%	Sold -43.16% shares Q4 2021
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 3.42% Portfolio value: 94.59M Avg. open price: $85.11 Current price: $103.53 P/L: +21.64% Bought +32.95% shares Q3 2022	share	3.42%	94.59M	$85.11	$103.53	+21.64%	Bought +32.95% shares Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 3.20% Portfolio value: 88.50M Avg. open price: $16.3 Current price: $33.96 P/L: +108.35% Bought +1.10% shares Q3 2022	share	3.20%	88.50M	$16.3	$33.96	+108.35%	Bought +1.10% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 3.13% Portfolio value: 86.56M Avg. open price: $62.73 Current price: $86.35 P/L: +37.66% Bought +12.96% shares Q4 2021	share	3.13%	86.56M	$62.73	$86.35	+37.66%	Bought +12.96% shares Q4 2021
Healthcare Plans Humana Inc. Portfolio share: 2.92% Portfolio value: 80.57M Avg. open price: $274.59 Current price: $547.42 P/L: +99.36% Bought +19.11% shares Q1 2022	share	2.92%	80.57M	$274.59	$547.42	+99.36%	Bought +19.11% shares Q1 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 2.76% Portfolio value: 76.23M Avg. open price: $142.82 Current price: $150.97 P/L: +5.70% Bought +10.75% shares Q2 2022	share	2.76%	76.23M	$142.82	$150.97	+5.70%	Bought +10.75% shares Q2 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 2.68% Portfolio value: 74.05M Avg. open price: $38.3 Current price: $77.29 P/L: +101.80% Bought +21.99% shares Q3 2022	share	2.68%	74.05M	$38.3	$77.29	+101.80%	Bought +21.99% shares Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 2.47% Portfolio value: 68.26M Avg. open price: $121.95 Current price: $212 P/L: +73.85% Bought +96.97% shares Q3 2022	share	2.47%	68.26M	$121.95	$212	+73.85%	Bought +96.97% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 2.44% Portfolio value: 67.57M Avg. open price: $73.15 Current price: $98.48 P/L: +34.63% Sold -30.07% shares Q4 2021	share	2.44%	67.57M	$73.15	$98.48	+34.63%	Sold -30.07% shares Q4 2021
Biotechnology Caribou Biosciences, Inc. Portfolio share: 2.29% Portfolio value: 63.3M Avg. open price: $10.01 Current price: $9.14 P/L: -8.72% Bought +37.28% shares Q2 2022	share	2.29%	63.3M	$10.01	$9.14	-8.72%	Bought +37.28% shares Q2 2022
Medical Devices iRhythm Technologies, Inc. Portfolio share: 2.24% Portfolio value: 61.85M Avg. open price: $81.03 Current price: $102.75 P/L: +26.81% Sold -5.78% shares Q1 2022	share	2.24%	61.85M	$81.03	$102.75	+26.81%	Sold -5.78% shares Q1 2022
Biotechnology Erasca, Inc. Portfolio share: 2.05% Portfolio value: 56.66M Avg. open price: $6.91 Current price: $7.28 P/L: +5.43% Bought +23.53% shares Q3 2022	share	2.05%	56.66M	$6.91	$7.28	+5.43%	Bought +23.53% shares Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 2.04% Portfolio value: 56.33M Avg. open price: $192.74 Current price: $535.04 P/L: +177.60% Sold -23.22% shares Q4 2021	share	2.04%	56.33M	$192.74	$535.04	+177.60%	Sold -23.22% shares Q4 2021
Biotechnology Prothena Corporation plc Portfolio share: 1.84% Portfolio value: 50.94M Avg. open price: $27.15 Current price: $60.39 P/L: +122.43% Bought +143.47% shares Q3 2022	share	1.84%	50.94M	$27.15	$60.39	+122.43%	Bought +143.47% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 1.81% Portfolio value: 49.97M Avg. open price: $176.94 Current price: $121.22 P/L: -31.49% Bought +29.33% shares Q3 2022	share	1.81%	49.97M	$176.94	$121.22	-31.49%	Bought +29.33% shares Q3 2022
OAK STR HEALTH INC Portfolio share: 1.77% Portfolio value: 48.85M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	1.77%	48.85M	N/A	N/A	N/A	N/A Q3 2022
Healthcare Plans Molina Healthcare, Inc. Portfolio share: 1.72% Portfolio value: 47.42M Avg. open price: $78.67 Current price: $335.11 P/L: +325.99% Bought +105.14% shares Q1 2022	share	1.72%	47.42M	$78.67	$335.11	+325.99%	Bought +105.14% shares Q1 2022
AERIE PHARMACEUTICALS INC Portfolio share: 1.71% Portfolio value: 47.38M Avg. open price: N/A Current price: N/A P/L: N/A Sold -7.14% shares Q1 2021	share	1.71%	47.38M	N/A	N/A	N/A	Sold -7.14% shares Q1 2021
BIOMARIN PHARMACEUTICAL INC Portfolio share: 1.65% Portfolio value: 45.60M Avg. open price: N/A Current price: N/A P/L: N/A Bought +13.92% shares Q1 2021	share	1.65%	45.60M	N/A	N/A	N/A	Bought +13.92% shares Q1 2021
Technology Select Sector SPDR Fund Portfolio share: 1.65% Portfolio value: 45.55M Avg. open price: N/A Current price: $133.11 P/L: N/A N/A Q3 2022	put	1.65%	45.55M	N/A	$133.11	N/A	N/A Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 1.64% Portfolio value: 45.37M Avg. open price: $217.2 Current price: $267.97 P/L: +23.37% Bought +2.59% shares Q1 2021	share	1.64%	45.37M	$217.2	$267.97	+23.37%	Bought +2.59% shares Q1 2021
Biotechnology uniQure N.V. Portfolio share: 1.62% Portfolio value: 44.89M Avg. open price: $38.9 Current price: $25.65 P/L: -34.06% Bought +7.02% shares Q3 2022	share	1.62%	44.89M	$38.9	$25.65	-34.06%	Bought +7.02% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 1.61% Portfolio value: 44.53M Avg. open price: $248.86 Current price: $292.75 P/L: +17.63% N/A Q3 2022	call	1.61%	44.53M	$248.86	$292.75	+17.63%	N/A Q3 2022
Medical Distribution Cardinal Health, Inc. Portfolio share: 1.54% Portfolio value: 42.66M Avg. open price: N/A Current price: $79.48 P/L: N/A N/A Q4 2021	share	1.54%	42.66M	N/A	$79.48	N/A	N/A Q4 2021
Drug Manufacturers—General AbbVie Inc. Portfolio share: 1.54% Portfolio value: 42.56M Avg. open price: $67.92 Current price: $163.96 P/L: +141.42% Bought +28.81% shares Q3 2022	share	1.54%	42.56M	$67.92	$163.96	+141.42%	Bought +28.81% shares Q3 2022
Diagnostics & Research IQVIA Holdings Inc. Portfolio share: 1.50% Portfolio value: 41.49M Avg. open price: $137 Current price: $211.93 P/L: +54.70% Bought +3.33% shares Q3 2022	share	1.50%	41.49M	$137	$211.93	+54.70%	Bought +3.33% shares Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 1.47% Portfolio value: 40.76M Avg. open price: $23.41 Current price: $22.35 P/L: -4.51% Sold -6.73% shares Q2 2021	share	1.47%	40.76M	$23.41	$22.35	-4.51%	Sold -6.73% shares Q2 2021
Biotechnology Verve Therapeutics, Inc. Portfolio share: 1.45% Portfolio value: 40.14M Avg. open price: $19.77 Current price: $21.42 P/L: +8.37% Bought +38.29% shares Q3 2022	share	1.45%	40.14M	$19.77	$21.42	+8.37%	Bought +38.29% shares Q3 2022
Drug Manufacturers—Specialty & Generic Dynavax Technologies Corporation Portfolio share: 1.44% Portfolio value: 39.72M Avg. open price: $15.14 Current price: $12.3 P/L: -18.76% Bought +15.89% shares Q4 2021	share	1.44%	39.72M	$15.14	$12.3	-18.76%	Bought +15.89% shares Q4 2021
Medical Devices Edwards Lifesciences Corporation Portfolio share: 1.44% Portfolio value: 39.68M Avg. open price: $43.93 Current price: $73.85 P/L: +68.10% Bought +42.02% shares Q3 2022	share	1.44%	39.68M	$43.93	$73.85	+68.10%	Bought +42.02% shares Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 1.42% Portfolio value: 39.34M Avg. open price: $121.95 Current price: $212 P/L: +73.85% N/A Q3 2022	call	1.42%	39.34M	$121.95	$212	+73.85%	N/A Q3 2022
Healthcare Plans CIGNA CORP NEW Portfolio share: 1.42% Portfolio value: 39.20M Avg. open price: $141.73 Current price: $327.39 P/L: +130.99% Bought +50.10% shares Q2 2022	share	1.42%	39.20M	$141.73	$327.39	+130.99%	Bought +50.10% shares Q2 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 1.35% Portfolio value: 37.2M Avg. open price: $248.86 Current price: $292.75 P/L: +17.63% N/A Q3 2022	share	1.35%	37.2M	$248.86	$292.75	+17.63%	N/A Q3 2022
Biotechnology argenx SE Portfolio share: 1.34% Portfolio value: 36.97M Avg. open price: N/A Current price: $393.21 P/L: N/A N/A Q2 2022	share	1.34%	36.97M	N/A	$393.21	N/A	N/A Q2 2022
Medical Distribution McKesson Corporation Portfolio share: 1.30% Portfolio value: 35.96M Avg. open price: $172.35 Current price: $382.44 P/L: +121.90% Sold -40.22% shares Q1 2022	share	1.30%	35.96M	$172.35	$382.44	+121.90%	Sold -40.22% shares Q1 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 1.26% Portfolio value: 34.90M Avg. open price: N/A Current price: $6.72 P/L: N/A N/A Q3 2022	share	1.26%	34.90M	N/A	$6.72	N/A	N/A Q3 2022
Health Information Services Veeva Systems Inc. Portfolio share: 1.21% Portfolio value: 33.37M Avg. open price: N/A Current price: $167.24 P/L: N/A N/A Q2 2022	share	1.21%	33.37M	N/A	$167.24	N/A	N/A Q2 2022
Medical Care Facilities HCA Healthcare, Inc. Portfolio share: 1.17% Portfolio value: 32.20M Avg. open price: $79.79 Current price: $235.35 P/L: +194.97% N/A Q3 2022	share	1.17%	32.20M	$79.79	$235.35	+194.97%	N/A Q3 2022
Diagnostics & Research Waters Corporation Portfolio share: 1.15% Portfolio value: 31.70M Avg. open price: $254.64 Current price: $340.29 P/L: +33.64% Bought +4.02% shares Q2 2021	share	1.15%	31.70M	$254.64	$340.29	+33.64%	Bought +4.02% shares Q2 2021
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 1.14% Portfolio value: 31.63M Avg. open price: $57.01 Current price: $68.42 P/L: +20.02% Bought +27.53% shares Q2 2022	share	1.14%	31.63M	$57.01	$68.42	+20.02%	Bought +27.53% shares Q2 2022
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 1.14% Portfolio value: 31.51M Avg. open price: $406.83 Current price: $557.21 P/L: +36.96% Sold -13.02% shares Q4 2021	share	1.14%	31.51M	$406.83	$557.21	+36.96%	Sold -13.02% shares Q4 2021
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 1.12% Portfolio value: 31.04M Avg. open price: N/A Current price: $110.01 P/L: N/A Sold -62.91% shares Q3 2022	share	1.12%	31.04M	N/A	$110.01	N/A	Sold -62.91% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 1.12% Portfolio value: 30.97M Avg. open price: $20.5 Current price: $25.44 P/L: +24.12% Bought +121.96% shares Q3 2022	share	1.12%	30.97M	$20.5	$25.44	+24.12%	Bought +121.96% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 1.06% Portfolio value: 29.30M Avg. open price: $37.15 Current price: $226.95 P/L: +510.85% Sold -37.09% shares Q2 2022	share	1.06%	29.30M	$37.15	$226.95	+510.85%	Sold -37.09% shares Q2 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 1.02% Portfolio value: 28.09M Avg. open price: $28.04 Current price: $44.6 P/L: +59.09% Bought +3.55% shares Q1 2022	share	1.02%	28.09M	$28.04	$44.6	+59.09%	Bought +3.55% shares Q1 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.99% Portfolio value: 27.24M Avg. open price: N/A Current price: $11.58 P/L: N/A N/A Q2 2022	share	0.99%	27.24M	N/A	$11.58	N/A	N/A Q2 2022
Medical Devices Nevro Corp. Portfolio share: 0.95% Portfolio value: 26.26M Avg. open price: $89.79 Current price: $43.47 P/L: -51.59% Sold -14.54% shares Q3 2022	share	0.95%	26.26M	$89.79	$43.47	-51.59%	Sold -14.54% shares Q3 2022
Diagnostics & Research ICON Public Limited Company Portfolio share: 0.90% Portfolio value: 24.76M Avg. open price: $138.57 Current price: $204.76 P/L: +47.77% Sold -14.82% shares Q3 2022	share	0.90%	24.76M	$138.57	$204.76	+47.77%	Sold -14.82% shares Q3 2022
Medical Instruments & Supplies ICU Medical, Inc. Portfolio share: 0.87% Portfolio value: 24.13M Avg. open price: $221.42 Current price: $156.19 P/L: -29.46% Sold -33.83% shares Q3 2022	share	0.87%	24.13M	$221.42	$156.19	-29.46%	Sold -33.83% shares Q3 2022
Drug Manufacturers—General Johnson & Johnson Portfolio share: 0.81% Portfolio value: 22.50M Avg. open price: $172.82 Current price: $178.78 P/L: +3.45% Sold -77.60% shares Q3 2022	share	0.81%	22.50M	$172.82	$178.78	+3.45%	Sold -77.60% shares Q3 2022
Medical Devices PROCEPT BioRobotics Corporation Portfolio share: 0.78% Portfolio value: 21.45M Avg. open price: $32.69 Current price: $45.58 P/L: +39.43% Bought +44.77% shares Q3 2022	share	0.78%	21.45M	$32.69	$45.58	+39.43%	Bought +44.77% shares Q3 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 0.70% Portfolio value: 19.29M Avg. open price: $77.92 Current price: $42.01 P/L: -46.09% Bought +111.21% shares Q3 2022	share	0.70%	19.29M	$77.92	$42.01	-46.09%	Bought +111.21% shares Q3 2022
Medical Care Facilities Oak Street Health, Inc. Portfolio share: 0.64% Portfolio value: 17.72M Avg. open price: $28.94 Current price: $21.94 P/L: -24.19% Bought +16.82% shares Q3 2022	share	0.64%	17.72M	$28.94	$21.94	-24.19%	Bought +16.82% shares Q3 2022
Biotechnology Generation Bio Co. Portfolio share: 0.58% Portfolio value: 16.00M Avg. open price: $7.26 Current price: $5.22 P/L: -28.13% Bought +8.67% shares Q3 2022	share	0.58%	16.00M	$7.26	$5.22	-28.13%	Bought +8.67% shares Q3 2022
Biotechnology Editas Medicine, Inc. Portfolio share: 0.57% Portfolio value: 15.65M Avg. open price: $11.83 Current price: $9.83 P/L: -16.91% Bought +103.13% shares Q3 2022	share	0.57%	15.65M	$11.83	$9.83	-16.91%	Bought +103.13% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 0.55% Portfolio value: 15.25M Avg. open price: $85.11 Current price: $103.53 P/L: +21.64% N/A Q3 2022	call	0.55%	15.25M	$85.11	$103.53	+21.64%	N/A Q3 2022
Diagnostics & Research Myriad Genetics, Inc. Portfolio share: 0.51% Portfolio value: 14.16M Avg. open price: $30.45 Current price: $20.01 P/L: -34.29% Sold -36.96% shares Q3 2022	share	0.51%	14.16M	$30.45	$20.01	-34.29%	Sold -36.96% shares Q3 2022
Biotechnology Werewolf Therapeutics, Inc. Portfolio share: 0.46% Portfolio value: 12.69M Avg. open price: $4.86 Current price: $1.75 P/L: -63.98% Bought +62.69% shares Q3 2022	share	0.46%	12.69M	$4.86	$1.75	-63.98%	Bought +62.69% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 0.42% Portfolio value: 11.71M Avg. open price: N/A Current price: $522.34 P/L: N/A Sold -39.63% shares Q3 2022	share	0.42%	11.71M	N/A	$522.34	N/A	Sold -39.63% shares Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.42% Portfolio value: 11.62M Avg. open price: $54.97 Current price: $21.42 P/L: -61.03% N/A Q3 2022	share	0.42%	11.62M	$54.97	$21.42	-61.03%	N/A Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 0.37% Portfolio value: 10.24M Avg. open price: N/A Current price: $20.04 P/L: N/A N/A Q2 2022	share	0.37%	10.24M	N/A	$20.04	N/A	N/A Q2 2022
Biotechnology PMV Pharmaceuticals, Inc. Portfolio share: 0.37% Portfolio value: 10.17M Avg. open price: $21.28 Current price: $9.89 P/L: -53.52% Sold -29.57% shares Q3 2022	share	0.37%	10.17M	$21.28	$9.89	-53.52%	Sold -29.57% shares Q3 2022
Biotechnology Adaptimmune Therapeutics plc Portfolio share: 0.36% Portfolio value: 10.02M Avg. open price: $3.58 Current price: $1.95 P/L: -45.48% Bought +2.31% shares Q3 2022	share	0.36%	10.02M	$3.58	$1.95	-45.48%	Bought +2.31% shares Q3 2022
Biotechnology Jounce Therapeutics, Inc. Portfolio share: 0.35% Portfolio value: 9.58M Avg. open price: $12.19 Current price: $0.91 P/L: -92.55% Bought +3.67% shares Q3 2022	share	0.35%	9.58M	$12.19	$0.91	-92.55%	Bought +3.67% shares Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 0.31% Portfolio value: 8.59M Avg. open price: $41.87 Current price: $50.19 P/L: +19.87% N/A Q3 2022	share	0.31%	8.59M	$41.87	$50.19	+19.87%	N/A Q3 2022
NEVRO CORP Portfolio share: 0.31% Portfolio value: 8.51M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.31%	8.51M	N/A	N/A	N/A	N/A Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.30% Portfolio value: 8.32M Avg. open price: N/A Current price: $49.41 P/L: N/A N/A Q3 2022	share	0.30%	8.32M	N/A	$49.41	N/A	N/A Q3 2022
Biotechnology Praxis Precision Medicines, Inc. Portfolio share: 0.28% Portfolio value: 7.85M Avg. open price: $11 Current price: $2.14 P/L: -80.55% Bought +4.89% shares Q3 2022	share	0.28%	7.85M	$11	$2.14	-80.55%	Bought +4.89% shares Q3 2022
Medical Care Facilities Cano Health, Inc. Portfolio share: 0.24% Portfolio value: 6.73M Avg. open price: N/A Current price: $2.09 P/L: N/A N/A Q3 2022	share	0.24%	6.73M	N/A	$2.09	N/A	N/A Q3 2022
DYNAVAX TECHNOLOGIES CORP Portfolio share: 0.23% Portfolio value: 6.32M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.23%	6.32M	N/A	N/A	N/A	N/A Q2 2022
Biotechnology IO Biotech, Inc. Portfolio share: 0.21% Portfolio value: 5.85M Avg. open price: $5.3 Current price: $2.81 P/L: -46.98% Bought +58.51% shares Q2 2022	share	0.21%	5.85M	$5.3	$2.81	-46.98%	Bought +58.51% shares Q2 2022
Biotechnology Prothena Corporation plc Portfolio share: 0.18% Portfolio value: 4.88M Avg. open price: $27.15 Current price: $60.39 P/L: +122.43% N/A Q3 2022	call	0.18%	4.88M	$27.15	$60.39	+122.43%	N/A Q3 2022
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.17% Portfolio value: 4.65M Avg. open price: N/A Current price: $10.04 P/L: N/A Sold -7.18% shares Q1 2021	share	0.17%	4.65M	N/A	$10.04	N/A	Sold -7.18% shares Q1 2021
Shell Companies Jiya Acquisition Corp. Portfolio share: 0.17% Portfolio value: 4.62M Avg. open price: N/A Current price: $10.04 P/L: N/A Sold -7.18% shares Q1 2021	share	0.17%	4.62M	N/A	$10.04	N/A	Sold -7.18% shares Q1 2021
Biotechnology IVERIC bio, Inc. Portfolio share: 0.17% Portfolio value: 4.59M Avg. open price: N/A Current price: $21.89 P/L: N/A Sold -71.71% shares Q3 2022	share	0.17%	4.59M	N/A	$21.89	N/A	Sold -71.71% shares Q3 2022
Medical Care Facilities COMPASS Pathways plc Portfolio share: 0.15% Portfolio value: 4.26M Avg. open price: $10.82 Current price: $10.79 P/L: -0.28% Bought +1.26% shares Q3 2022	share	0.15%	4.26M	$10.82	$10.79	-0.28%	Bought +1.26% shares Q3 2022
Biotechnology Sana Biotechnology, Inc. Portfolio share: 0.15% Portfolio value: 4.14M Avg. open price: $8.26 Current price: $4.35 P/L: -47.34% Sold -27.42% shares Q3 2022	share	0.15%	4.14M	$8.26	$4.35	-47.34%	Sold -27.42% shares Q3 2022
Medical Devices Pulmonx Corporation Portfolio share: 0.12% Portfolio value: 3.32M Avg. open price: $35.98 Current price: $6.18 P/L: -82.82% N/A Q3 2022	share	0.12%	3.32M	$35.98	$6.18	-82.82%	N/A Q3 2022
Biotechnology ESSA Pharma Inc. Portfolio share: 0.10% Portfolio value: 2.69M Avg. open price: $3.15 Current price: $3.47 P/L: +10.16% Bought +53.71% shares Q3 2022	share	0.10%	2.69M	$3.15	$3.47	+10.16%	Bought +53.71% shares Q3 2022
Health Information Services SOPHiA GENETICS SA Portfolio share: 0.08% Portfolio value: 2.31M Avg. open price: $13.17 Current price: $2.05 P/L: -84.43% Sold -50.18% shares Q3 2022	share	0.08%	2.31M	$13.17	$2.05	-84.43%	Sold -50.18% shares Q3 2022
Medical Devices Sight Sciences, Inc. Portfolio share: 0.05% Portfolio value: 1.44M Avg. open price: N/A Current price: $11.71 P/L: N/A Sold -70.67% shares Q3 2022	share	0.05%	1.44M	N/A	$11.71	N/A	Sold -70.67% shares Q3 2022
Biotechnology Celcuity Inc. Portfolio share: 0.05% Portfolio value: 1.41M Avg. open price: N/A Current price: $8.06 P/L: N/A N/A Q3 2022	share	0.05%	1.41M	N/A	$8.06	N/A	N/A Q3 2022
Biotechnology Zai Lab Limited Portfolio share: 0.03% Portfolio value: 808K Avg. open price: N/A Current price: $33.74 P/L: N/A N/A Q3 2022	share	0.03%	808K	N/A	$33.74	N/A	N/A Q3 2022
Biotechnology Pardes Biosciences, Inc. Portfolio share: 0.02% Portfolio value: 528K Avg. open price: $15.44 Current price: $1.1 P/L: -92.88% Sold -64.41% shares Q3 2022	share	0.02%	528K	$15.44	$1.1	-92.88%	Sold -64.41% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $248.86 Current price: $292.75 P/L: +17.63% Sold -100.00% shares Q3 2022	call	0.00%	0	$248.86	$292.75	+17.63%	Sold -100.00% shares Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.58 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$11.58	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $72.6 Current price: $50.77 P/L: -30.06% Sold -100.00% shares Q3 2022	share	0.00%	0	$72.6	$50.77	-30.06%	Sold -100.00% shares Q3 2022
Medical Care Facilities Universal Health Services, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $133.72 Current price: $127.36 P/L: -4.75% Sold -100.00% shares Q3 2022	share	0.00%	0	$133.72	$127.36	-4.75%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies Becton, Dickinson and Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $140.78 Current price: $246.21 P/L: +74.89% Sold -100.00% shares Q3 2022	share	0.00%	0	$140.78	$246.21	+74.89%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies Baxter International Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $58.6 Current price: $51.3 P/L: -12.46% Sold -100.00% shares Q3 2022	share	0.00%	0	$58.6	$51.3	-12.46%	Sold -100.00% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $176.94 Current price: $121.22 P/L: -31.49% Sold -100.00% shares Q3 2022	call	0.00%	0	$176.94	$121.22	-31.49%	Sold -100.00% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $37.15 Current price: $226.95 P/L: +510.85% Sold -100.00% shares Q3 2022	call	0.00%	0	$37.15	$226.95	+510.85%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Aerie Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $40.15 Current price: $15.25 P/L: -62.01% Sold -100.00% shares Q3 2022	share	0.00%	0	$40.15	$15.25	-62.01%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Pfizer Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $36.34 Current price: $50.73 P/L: +39.61% Sold -100.00% shares Q3 2022	share	0.00%	0	$36.34	$50.73	+39.61%	Sold -100.00% shares Q3 2022
Biotechnology ACADIA Pharmaceuticals Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $31.72 Current price: $15.24 P/L: -51.96% Sold -100.00% shares Q3 2022	share	0.00%	0	$31.72	$15.24	-51.96%	Sold -100.00% shares Q3 2022

Showing TOP 96 PFM HEALTH SCIENCES, LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of PFM HEALTH SCIENCES, LP?

The biggest position of the PFM HEALTH SCIENCES, LP is Cytokinetics, Incorporated (CYTK) with 4.32% portfolio share worth of 119.43M US dollars.

Top 5 PFM HEALTH SCIENCES, LP's holdings represent 17.57% of the portfolio:

Cytokinetics, Incorporated (CYTK) – 4.32%
Eli Lilly and Company (LLY) – 3.49%
BioMarin Pharmaceutical Inc. (BMRN) – 3.42%
Arcus Biosciences, Inc. (RCUS) – 3.2%
Centene Corporation (CNC) – 3.13%

Who is the portfolio manager of PFM HEALTH SCIENCES, LP?

The portfolio manager of the PFM HEALTH SCIENCES, LP is .

What is the total asset value of the PFM HEALTH SCIENCES, LP portfolio?

PFM HEALTH SCIENCES, LP total asset value (portfolio value) is 2.76B US dollars.

Who is ?

is the portfolio manager of the PFM HEALTH SCIENCES, LP.

What is (PFM HEALTH SCIENCES, LP) fund performance?

PFM HEALTH SCIENCES, LP's quarterly performance is -0.39%, annualy -23.38%. In the past 3 years, the value of 's portfolio has increased by +12%. In the past 5 years, the value of the portfolio has increased by +11%.

What is the PFM HEALTH SCIENCES, LP CIK?

PFM HEALTH SCIENCES, LP's Central Index Key is 0001442756 .

PFM HEALTH SCIENCES, LP Holdings

PFM HEALTH SCIENCES, LP portfolio value:

PFM HEALTH SCIENCES, LP quarter portfolio value change:

PFM HEALTH SCIENCES, LP 1 year portfolio value change:

PFM HEALTH SCIENCES, LP 3 years portfolio value change:

PFM HEALTH SCIENCES, LP 5 years portfolio value change: